Daniel Friedman

Daniel Friedman

Direttore/Membro del Consiglio presso PBS Biotech, Inc.

Finance
Consumer Services
Commercial Services

Profilo

Daniel Friedman is a Vice President on BroadOak’s growth capital investing team where he specializes in portfolio management and investment execution.
Prior to joining BroadOak in 2019, Daniel worked for Raymond James within the Life Sciences Investment Banking team where he focused on public financings and M&A for biotechnology and medical device companies.
Daniel currently serves as Secretary of the Board of Biolog as well as Board Observer at PBS Biotech.
Daniel previously acted as a board observer at both Avidien Technologies and antibodies-online.
Daniel earned a B.B.A.
with concentrations in finance and accounting from the Ross School of Business at the University of Michigan.

Posizioni attive di Daniel Friedman

SocietàPosizioneInizio
Investitore di Private Equity 01/01/2022
Direttore/Membro del Consiglio 01/09/2023
Tutte le posizioni attive di Daniel Friedman

Formazione di Daniel Friedman

Stephen M. Ross School of Business Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Daniel Friedman

Relazioni

100 +

Relazioni di 1° grado

3

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private2

Finance

Commercial Services

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Daniel Friedman